Palvella Therapeutics PVLA
NASDAQ PVLA
$126.58 +2.66 (+2.15%)
At close: Oct 21, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Preferred Shares (2016 - 2017)

Updated

Palvella Therapeutics' Preferred Shares was $5.00 in Q3 2017, unchanged from $5.00 a year earlier and unchanged from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Preferred Shares (2016 - 2017) Analysis & Trends

From Q2 2016 onward, Palvella Therapeutics has reported Preferred Shares for 5 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Palvella Therapeutics 1.82 Bn 1.57 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 5.00
Jun 30, 2017 5.00
Mar 31, 2017 5.00
Sep 30, 2016 5.00
Jun 30, 2016 5.00
API Access

Palvella Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=PVLA&period=max&api_key=YOUR_API_KEY